Management Team
NovaScan has a capable, highly experienced leadership team.
Craig Davis
Chief Executive Officer
Craig has been active in the early stage medtech community for many years, as a partner at a leading family office, as a medtech investment banker, and as a growth strategy consultant. Previous to NovaScan, Mr. Davis was a partner in the two person family office LaSalle Investments. Among others, LaSalle co-founded Merge Healthcare (IPO and sold to IBM for $1Billion) and OrthoScan (acquired by ATON GmbH). Craig was a senior member of a team that was backed by private equity firm GTCR to roll up companies in the urologic device space. He is also an ex- partner at Healthios, a boutique healthcare focused investment bank founded by former Baxter CEO Vern Loucks. Mr. Davis has an MBA from the Kellogg School, a masters degrees in engineering from Northwestern, as well as a BS in mechanical engineering from Washington University.
Christen Springs
GM Lung and GI
Christen Springs has more than twenty years of device experience, fifteen of which are in senior leadership roles. Christen founded and leads a consulting firm called EndoRx where he guides disruptive medical device technologies towards strategic exits. He has led three different precommercial exits in the GI device space. Previous to EndoRx, Mr Springs was VP of Sales and Business Development at RadiaDyne, a cancer company that was acquired by AngioDynamics.
Donato M. Ceres Ph.D.
Chief Science Officer
Dr. Ceres brings to NovaScan expertise in nanotechnology and electrochemical diagnostic devices. He has 16 years of entrepreneurial and technology management experience in driving product development from state-of-the-art and emerging technologies while serving in various leading roles in several startup companies. Dr. Ceres also served as Scientific Advisor for Angel investment groups in Los Angeles and Chicago. He received his Ph.D. in Chemistry from Caltech and MS in Physics from the EPFL (Swiss Federal Institute of Technology in Lausanne, Switzerland).
William Gregory, Ph.D.
Founder
Over the past thirty years, Dr. Gregory has been researching the electrical properties of materials and has been involved in other start-up companies as well as holding various academic positions. He holds numerous patents and is widely published, and most recently a joint appointment as a Professor of Electrical Engineering in the College of Engineering and in the College of Health Sciences at the University of Wisconsin, Milwaukee. Prior to this position, Dr. Gregory was the Dean of the College of Engineering and Applied Science at UW-Milwaukee. Dr. Gregory received his Ph.D. in Physics from MIT, is a registered patent agent and holds a professional engineering license.
Martina Guidetti, Ph.D
Medical Liason
Dr. Guidetti leads NovaScan’s engagement with the medical community. She has previously engaged in a number of medically related innovations, included Magnetic Resonance Elastography and imaging algorithms for surgical planning of hip joint syndromes. Martina’s work has been published in both engineering and clinical journals. Previous to NovaScan, Martina completed a PostDoc in the orthopedic department of Rush University Medical Center. Martina received both a masters and PhD in bioengineering from the University of Illinois at Chicago. She also attended Politecnico di Milano in Italy, where she completed an MS and BS in biomedical engineering.
Mark Shapiro, Ph.D.
Senior Data Science Advisor
An expert on artificial intelligence and machine learning, Dr Mark Shapiro leads the implementation of these technologies in NovaScan devices. More recently, he has focused on digital transformation in healthcare at Elevance Health (formerly Anthem), where he built an R&D team specializing in the application of Machine Learning and Artificial Intelligence (AI/ML) in healthcare. Additionally, he led collaborations with researchers from the University of Illinois at Chicago, University of Colorado, and Northwestern University, resulting in several successful projects and peer-reviewed publications. Previous to Elevance, Dr Shapiro lead multiple data science and machine learning initiatives at Deloitte, and he held a leadership role at Kogentix, a machine learning startup that was acquired by Accenture. Mark obtained a Ph.D in electrical engineering from the University of Illinois at Chicago. He spent the early years of his career in academia, and he is widely published in neurophysiology, clinical research and AI/ML.